logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Benidipine Hydrochloride CAS 91599-74-5

Benidipine Hydrochloride CAS 91599-74-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 91599-74-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
91599-74-5
Appearance::
Yellow Powder
Molecular Formula::
C28H31N3O6
Molecular Weight::
505.56200
EINECS NO::
663-500-3
MDL NO::
MFCD91599745
CAS NO::
91599-74-5
Appearance::
Yellow Powder
Molecular Formula::
C28H31N3O6
Molecular Weight::
505.56200
EINECS NO::
663-500-3
MDL NO::
MFCD91599745
Benidipine Hydrochloride CAS 91599-74-5

Product Description:

Product Name: Benidipine hydrochloride CAS NO: 91599-74-5

 

 

Synonyms:

(+-)-Benidipine hydrochloride;

5-O-methyl3-O-[1-(phenylmethyl)-piperidin-3-yl]2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride;

3,5-Pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,methyl1-(phenylmethyl)-3-piperidinyl ester,monohydrochloride,(R*,R*)-(+-);

 

 

Chemical & Physical Properties:

Appearance: Yellow powder

Assay :≥99.00%

Boiling Point: 645.9℃ at 760 mmHg

Melting Point: 199-201℃

Flash Point: 344.4℃

Storage Condition: Desiccate at RT

 

 

Safety Information:

HS Code: 2942000000

Hazard Code: T

Risk Statement: R25

Safety Statement: S45

RIDADR: UN 2811 6.1 / PGIII

WGK Germany: 3

RTECS: US7975657

 

 

A dihydropyridine calcium channel blocker. Antihypertensive. Benidipine hydrochloride is a new, long acting dihydropyridine calcium antagonist useful in the treatment of hypertension and angina pectoris. In experimental animals, benidipine hydrochloride dose dependently induced hypotension with a potency of 6 and 12 times more than nifedipine and nicardipine, respectively. It also exhibited a slow onset of action.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.